XingImaging, LLC

XingImaging provides services across the pre-clinical and clinical spectrum including radioligand development and manufacturing, design and implementation of Phase 1 to Phase 4 clinical trials, and customized clinical imaging site coordination and management in multi-site imaging studies. Our strong emphasis is on research using investigational radiotracers with quantitative imaging outcome measures as diagnostic tools and or for assessing disease mechanism or progression. Our focus is on developing radioligands as tools for human research. Our research staff has leadership roles in numerous clinical imaging trials and in several research consortiums and international research organizations focused on clinical neuroscience and nuclear medicine aimed at advancing knowledge regarding the causes and developing more effective treatments for neurodegenerative disorders. XingImaging's research facility has the capability to conduct imaging research in a comprehensive yet highly efficient manner. XingImaging takes great pride in delivering high quality services. We believe that compliance with regulations and continuous improvement of our processes will benefit you as well as the business. Within XingImaging we are committed to: Provide our sponsors with satisfaction in all services Provide compassionate and confidential care to our research participants Compliance with laws and regulations pertaining to the quality and safety requirements in all countries in which our services are offered Continual improvement in the effectiveness of XingImaging's Quality Program XingImaging is based in New Haven, CT with over 24,000 sq ft. of research space and over 40 staff members. Our team is organized into Clinical, Chemistry, and Imaging Sciences divisions with administrative and project support including Regulatory Affairs, Quality Assurance, Imaging and Data Management Services, Information Technology, and Business Operations.